SKI Market

A+| A| A-|

Indian Indices

Sensex

77,987.92 801.05
( 1.04%)

Global Indices

Nasdaq

52,569.33 -110.31
(-0.21%)

Dow Jones

7,555.54 -37.86
(-0.50%)

Hang Seng

63,887.74 -2,947.80
(-4.41%)

Nikkei 225

10,555.24 39.32
(0.37%)

Forex

USD-INR

96.26 0.11
(0.12%)

EUR-INR

110.12 0.41
(0.38%)

GBP-INR

129.49 0.88
(0.69%)

JPY-INR

0.59 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

36.4615746

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

41.5

12486.93

EPS(TTM)

Face Value()

Div & Yield %

6.64

0.33

Back

Octal Credit Capital reports consolidated net loss of Rs 0.33 crore in the December 2025 quarter

Feb 13,2026

Net Loss of Octal Credit Capital reported to Rs 0.33 crore in the quarter ended December 2025 as against net loss of Rs 0.54 crore during the previous quarter ended December 2024. Sales rose 55.56% to Rs 0.14 crore in the quarter ended December 2025 as against Rs 0.09 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0.14	0.09	56
OPM %	-235.71	-600.00	-
PBDT	-0.33	-0.54	39
PBT	-0.33	-0.54	39
NP	-0.33	-0.54	39

77,987.92 801.05 ( 1.04%)

52,569.33 -110.31 (-0.21%)

7,555.54 -37.86 (-0.50%)

63,887.74 -2,947.80 (-4.41%)

10,555.24 39.32 (0.37%)

96.26 0.11 (0.12%)

110.12 0.41 (0.38%)

129.49 0.88 (0.69%)

0.59 0.00 (0.14%)